10/16/2019  4:58:30 PM Chg. +4.26 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
87.43USD +5.12% 84,194
Turnover: 7.36 mill.
-Bid Size: - -Ask Size: - 17.33 bill.USD 1.83% 10.93

Business description

AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health.
 

Management board & Supervisory board

CEO
Steven H. Collis
Management board
James F. Cleary, Jr., Dale Danilewitz, Gina K. Clark, Hyung Bak, J.F. Quinn, John G. Chou, Kathy H. Gaddes, Lazarus Krikorian, Robert P. Mauch, Silvana Battaglia
Supervisory board
Steven H. Collis, D. Mark Durcan, Henry W. McGee, Jane E. Henney, Kathleen W. Hyle, Lon R. Greenberg, Michael J. Long, Ornella Barra, Richard W. Gochnauer
 

Company data

Name: AmerisourceBergen Corp.
Address: 1300 Morris Drive,Chesterbrook, PA 19087-5594, USA
Phone: +1-610-727-7000
Fax: -
E-mail: -
Internet: www.amerisourcebergen.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Medical Supplies
End of financial year: 9/30
Free Float: 61.10%
IPO date: -

Investor relations

Name: Bennett Murphy
IR phone: +1-610-727-3693
IR Fax: +1-610-727-3603
IR e-mail: InvestorRelations@am...gen.com InvestorRelations@amerisourcebergen.com

Main Shareholders

Freefloat
 
61.10%
Walgreens Boots Alliance Holdings LLC
 
26.00%
The Vanguard Group Inc.
 
6.80%
Blackrock, Inc.
 
6.10%